Paper39449255
Therapeutic liver cell transplantation to treat murine PKU.
Willimann M and 6 others. J Inherit Metab Dis, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Therapeutic liver cell transplantation to treat murine PKU. Papers, record 39449255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39449255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phenylketonurias | Major topic |
| Hepatocytes | Major topic |
| Disease Models, Animal | Major topic |
| Liver | Major topic |
| Genetic Therapy | Major topic |
| Animals | |
| Mice | |
| Acetaminophen | |
| Gene Editing | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 310030-162547 | Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | PubMed | ||
| CRSII5_180257 | Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | PubMed |
Source PubMed
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26780180 | Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. | Nat Biotechnol | 2016 | https://conductscience.org/library/papers/26780180 | PubMed |
| 2 | 12734191 | Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts-/- mice rescued by feeding neurotransmitter precursors and H4-biopterin. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12734191 | PubMed |
| 3 | 32572269 | Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. | Nat Biotechnol | 2020 | https://conductscience.org/library/papers/32572269 | PubMed |
| 4 | 36656942 | CRISPR technology: A decade of genome editing is only the beginning. | Science | 2023 | https://conductscience.org/library/papers/36656942 | PubMed |
| 5 | 32872311 | CRISPR-Cas9 DNA Base-Editing and Prime-Editing. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32872311 | PubMed |
| 6 | 39449255 | Therapeutic liver cell transplantation to treat murine PKU. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/39449255 | PubMed |
| 7 | 16930941 | Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. | Toxicol In Vitro | 2006 | https://conductscience.org/library/papers/16930941 | PubMed |
| 8 | 15585113 | Factors influencing the titer and infectivity of lentiviral vectors. | Hum Gene Ther | 2004 | https://conductscience.org/library/papers/15585113 | PubMed |
| 9 | 37293185 | Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy. | Mol Ther Nucleic Acids | 2023 | https://conductscience.org/library/papers/37293185 | PubMed |
| 10 | 35339387 | Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice. | Mol Genet Metab | 2022 | https://conductscience.org/library/papers/35339387 | PubMed |
| 11 | 29326962 | Emerging Issues in AAV-Mediated In Vivo Gene Therapy. | Mol Ther Methods Clin Dev | 2018 | https://conductscience.org/library/papers/29326962 | PubMed |
| 12 | 25300484 | Easy quantitative assessment of genome editing by sequence trace decomposition. | Nucleic Acids Res | 2014 | https://conductscience.org/library/papers/25300484 | PubMed |
| 13 | 34084173 | Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes. | Front Immunol | 2021 | https://conductscience.org/library/papers/34084173 | PubMed |
| 14 | 28624210 | Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver Promoter. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28624210 | PubMed |
| 15 | 12161186 | Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. | Mol Ther | 2002 | https://conductscience.org/library/papers/12161186 | PubMed |
| 16 | 31970198 | Immune Response Mechanisms against AAV Vectors in Animal Models. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/31970198 | PubMed |
| 17 | 17170119 | In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. | Blood | 2007 | https://conductscience.org/library/papers/17170119 | PubMed |
| 18 | 33103516 | The development and hepatotoxicity of acetaminophen: reviewing over a century of progress. | Drug Metab Rev | 2020 | https://conductscience.org/library/papers/33103516 | PubMed |
| 19 | 33558455 | Viral vector platforms within the gene therapy landscape. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/33558455 | PubMed |
| 20 | 34531867 | Sex Differences in Immunity to Viral Infections. | Front Immunol | 2021 | https://conductscience.org/library/papers/34531867 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 39449255 | Therapeutic liver cell transplantation to treat murine PKU. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/39449255 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39449255
GET https://conductscience.org/api/papers/v1/39449255/references?page=2